CHINA / SOCIETY
By Global Times Published: May 13, 2021 10:43 PM Updated: May 14, 2021 12:09 AM
Photo taken on January 30, 2020 shows the headquarters of the World Health Organization in Geneva, Switzerland. Photo: Xinhua
Looking back at the past coronavirus ravaged year, an independent review panel said the pandemic, which killed more than 3.3 million people, was preventable. Learning a lesson from a catastrophe is never too late, especially for some parts of the world still engulfed by the pandemic, said a Chinese epidemiologist, lamenting that for some countries, especially the US, which still adopts short-term fixes and individualism in fighting the virus, it s a lesson they may never learn.
May Day holiday augurs full-fledged consumption recovery Tourists climb Huashan Mountain in Weinan, Northwest China’s Shaanxi Province on Wednesday, the last day of the country’s five-day May Day vacation. The tourist spot put a cap of 30,000 visits per day during the holiday due to coronavirus prevention precautions. Photo: Xinhua
China’s consumption engine has almost completely recovered to post-pandemic levels, as shown by surging spending on items from travel products to duty-free goods during the 2021 May Day holidays, which witnessed the country’s largest population movement after last year’s National Day holidays.
In Haikou, a city in South China’s Hainan Province, Chinese people made 65,400 purchases amounting to 485 million yuan ($75 million) on offshore duty-free goods from Saturday to Monday, the first three days of the May Day holidays, up 215.24 percent year-on-year.
Share this article
Share this article
HANGZHOU and SHAOXING, China, May 4, 2021 /PRNewswire/ Ascletis Pharma Inc. (HKEX:1672) today announces the positive Phase IIa clinical results of ASC22 (Envafolimab), which is a first-in-class, subcutaneously administered PD-L1 antibody for chronic hepatitis B (CHB) functional cure.
ASC22 Phase IIa clinical trial is a single dose escalation study of three subcutaneously administered doses (0.3, 1.0 and 2.5 mg/kg, three patients per dose) with 12-week follow-up to explore the safety and preliminary efficacy of ASC22 in CHB patients (ClinicalTrials.gov Identifier: NCT04465890). The primary efficacy endpoint is HBsAg reduction during 12-week follow-up after the single dose administration. Median baseline HBsAg of nine CHB patients enrolled was 3.0 log
China s consumption engine fully back to rolling, May Day holiday data shows
Zhao Yusha Published: May 05, 2021 11:09 PM Updated: May 06, 2021 12:17 AM
Tourists climb Huashan Mountain in Weinan, Northwest China’s Shaanxi Province on Wednesday, the last day of the country’s five-day May Day vacation. The tourist spot put a cap of 30,000 visits per day during the holiday due to coronavirus prevention precautions. Photo: Xinhua
China s consumption engine has almost completely recovered to post-pandemic levels, as shown by surging spending on items from travel products to duty-free goods during the 2021 May Day holidays, which witnessed the country s largest population movement after last year s National Day holidays.
Devastating epidemic may drag Indian economy back to 20 years ago ; China stands ready to help
Zhang Hui Published: Apr 24, 2021 07:31 PM
Multiple funeral pyres of COVID-19 victims burn at a site converted for mass cremations in New Delhi, India on Saturday. Indian authorities are scrambling to get medical oxygen to hospitals when the country reported a new global daily record of more than 346,000 infections for a third straight day. Photo: AP
As India suffers its worst humanitarian crisis amid the devastating second wave of COVID-19 with the fastest rise in new daily cases any country has experienced since the outbreak, the Chinese government and enterprises have made goodwill gestures by offering help or donating medical supplies despite sour bilateral ties.